290 related articles for article (PubMed ID: 25038088)
1. Revealing the results of whole-genome sequencing and whole-exome sequencing in research and clinical investigations: some ethical issues.
Hallowell N; Hall A; Alberg C; Zimmern R
J Med Ethics; 2015 Apr; 41(4):317-21. PubMed ID: 25038088
[TBL] [Abstract][Full Text] [Related]
2. Reporting results from whole-genome and whole-exome sequencing in clinical practice: a proposal for Canada?
Zawati MH; Parry D; Thorogood A; Nguyen MT; Boycott KM; Rosenblatt D; Knoppers BM
J Med Genet; 2014 Jan; 51(1):68-70. PubMed ID: 24078715
[TBL] [Abstract][Full Text] [Related]
3. Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies.
Chou J; Ohsumi TK; Geha RS
Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):623-8. PubMed ID: 23095910
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Exome and Genome Sequencing Technologies for the Complete Capture of Protein-Coding Regions.
Lelieveld SH; Spielmann M; Mundlos S; Veltman JA; Gilissen C
Hum Mutat; 2015 Aug; 36(8):815-22. PubMed ID: 25973577
[TBL] [Abstract][Full Text] [Related]
5. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.
Mackley MP; Fletcher B; Parker M; Watkins H; Ormondroyd E
Genet Med; 2017 Mar; 19(3):283-293. PubMed ID: 27584911
[TBL] [Abstract][Full Text] [Related]
6. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
[TBL] [Abstract][Full Text] [Related]
7. Military Health Care Dilemmas and Genetic Discrimination: A Family's Experience with Whole Exome Sequencing.
Helm BM; Langley K; Spangler BB; Schrier Vergano SA
Narrat Inq Bioeth; 2015; 5(2):179-86. PubMed ID: 26300150
[TBL] [Abstract][Full Text] [Related]
8. Meeting summary: Ethical aspects of whole exome and whole genome sequencing studies (WES/WGS) in rare diseases, Tel Aviv, Israel, January 2013.
Farberov L; Gilam A; Isakov O; Shomron N
Genet Res (Camb); 2013 Jun; 95(2-3):53-6. PubMed ID: 23938110
[TBL] [Abstract][Full Text] [Related]
9. Managing the ethical challenges of next-generation sequencing in genomic medicine.
Clarke AJ
Br Med Bull; 2014 Sep; 111(1):17-30. PubMed ID: 25122627
[TBL] [Abstract][Full Text] [Related]
10. Disclosing incidental findings in genetics contexts: a review of the empirical ethical research.
Christenhusz GM; Devriendt K; Dierickx K
Eur J Med Genet; 2013 Oct; 56(10):529-40. PubMed ID: 24036277
[TBL] [Abstract][Full Text] [Related]
11. Ethical issues raised by whole genome sequencing.
Pinxten W; Howard HC
Best Pract Res Clin Gastroenterol; 2014 Apr; 28(2):269-79. PubMed ID: 24810188
[TBL] [Abstract][Full Text] [Related]
12. Next-generation diagnostics: gene panel, exome, or whole genome?
Sun Y; Ruivenkamp CA; Hoffer MJ; Vrijenhoek T; Kriek M; van Asperen CJ; den Dunnen JT; Santen GW
Hum Mutat; 2015 Jun; 36(6):648-55. PubMed ID: 25772376
[TBL] [Abstract][Full Text] [Related]
13. Genetic counselors' views and experiences with the clinical integration of genome sequencing.
Machini K; Douglas J; Braxton A; Tsipis J; Kramer K
J Genet Couns; 2014 Aug; 23(4):496-505. PubMed ID: 24671342
[TBL] [Abstract][Full Text] [Related]
14. When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing.
Jamal L; Robinson JO; Christensen KD; Blumenthal-Barby J; Slashinski MJ; Perry DL; Vassy JL; Wycliff J; Green RC; McGuire AL
AJOB Empir Bioeth; 2017; 8(2):82-88. PubMed ID: 28949844
[TBL] [Abstract][Full Text] [Related]
15. The clinical utility of whole-exome sequencing in the context of rare diseases - the changing tides of medical practice.
Nguyen MT; Charlebois K
Clin Genet; 2015 Oct; 88(4):313-9. PubMed ID: 25421945
[TBL] [Abstract][Full Text] [Related]
16. On the ethics of clinical whole genome sequencing of children.
May T; Zusevics KL; Strong KA
Pediatrics; 2013 Aug; 132(2):207-9. PubMed ID: 23837175
[No Abstract] [Full Text] [Related]
17. Statement of principles on the return of research results and incidental findings in paediatric research: a multi-site consultative process.
Sénécal K; Rahimzadeh V; Knoppers BM; Fernandez CV; Avard D; Sinnett D
Genome; 2015 Dec; 58(12):541-8. PubMed ID: 26613133
[TBL] [Abstract][Full Text] [Related]
18. Content Analysis of Informed Consent for Whole Genome Sequencing Offered by Direct-to-Consumer Genetic Testing Companies.
Niemiec E; Borry P; Pinxten W; Howard HC
Hum Mutat; 2016 Dec; 37(12):1248-1256. PubMed ID: 27647801
[TBL] [Abstract][Full Text] [Related]
19. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.
Ackerman SL; Koenig BA
AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714
[TBL] [Abstract][Full Text] [Related]
20. [Concepts for the return of secondary genetic findings in medical diagnostics and research].
Fisher E; Achilles S; Tönnies H; Schmidtke J
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Feb; 58(2):166-73. PubMed ID: 25487853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
